Zerdes, I.; Wallerius, M.; Sifakis, E.G.; Wallmann, T.; Betts, S.; Bartish, M.; Tsesmetzis, N.; Tobin, N.P.; Coucoravas, C.; Bergh, J.;
et al. STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer. Cancers 2019, 11, 1479.
https://doi.org/10.3390/cancers11101479
AMA Style
Zerdes I, Wallerius M, Sifakis EG, Wallmann T, Betts S, Bartish M, Tsesmetzis N, Tobin NP, Coucoravas C, Bergh J,
et al. STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer. Cancers. 2019; 11(10):1479.
https://doi.org/10.3390/cancers11101479
Chicago/Turabian Style
Zerdes, Ioannis, Majken Wallerius, Emmanouil G. Sifakis, Tatjana Wallmann, Stina Betts, Margarita Bartish, Nikolaos Tsesmetzis, Nicholas P. Tobin, Christos Coucoravas, Jonas Bergh,
and et al. 2019. "STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer" Cancers 11, no. 10: 1479.
https://doi.org/10.3390/cancers11101479
APA Style
Zerdes, I., Wallerius, M., Sifakis, E. G., Wallmann, T., Betts, S., Bartish, M., Tsesmetzis, N., Tobin, N. P., Coucoravas, C., Bergh, J., Rassidakis, G. Z., Rolny, C., & Foukakis, T.
(2019). STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer. Cancers, 11(10), 1479.
https://doi.org/10.3390/cancers11101479